GL
George L Sing sold $1.9M of REGN stock
George L Sing, Dir of Regeneron Pharmaceuticals, Inc. (REGN), sold 2,000 shares of REGN stock worth $1.9M, per an SEC Form 4 filed Nov 18, 2026.
It was an open-market sale.
The trade happened on Nov 16, 2026, 2 days before it was made public.
REGN has moved -3.1% since the trade date, from $952.40 to $923.34 (Nov 19, 2026 close).
- Traded
- Nov 16, 2026
- Disclosed
- Nov 18, 2026
- Filing delay
- 2 days
- Price since
- -3.1%
- Role
- Dir
- Source
- SEC Form 4